The Medicines Company Seeks To Sharpen Angiomax Label With ACUITY Data

An acute coronary syndromes claim based on ACUITY would open up nearly 2 million additional potential patients per year for the anticoagulant, COO Kelley tells “The Pink Sheet” DAILY.